Skip to content
bioinnovationbeacon.com

bioinnovationbeacon.com

  • Home
  • AI
  • Biotech News
  • Research
  • Technology
  • Press Releases
  • Privacy Policy
  • Contact Us

Category: greenlight

GSK nabs FDA greenlight for second lung cancer asset from Nuvalent buy
greenlightResearch and Discovery

GSK nabs FDA greenlight for second lung cancer asset from Nuvalent buy

The FDA has granted accelerated approval to GSK’s tyrosine kinase inhibitor neladalkib for ALK-positive non-small cell lung cancer, marking the…

byadminNovember 18, 2026

| Depth News by Ascendoor | Powered by WordPress.